Add to ORKGPatients affected by liver cirrhosis are at high risk for developing hepatocellular carcinoma (HCC). The aim of this study was to evaluate the feasibility of PIVKA-II (protein induced by vitamin K absence or antagonist-II) alone or in combination with α-1 fetoprotein (AFP), as a screening marker for development of HCC
OBJECTIVE: As a marker for Hepatocellular Carcinoma (HCC), Protein Induced by Vitamin K Absence II (...
OBJECTIVE: α-Fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II ...
学位の種類: 博士（医学）. 報告番号: 乙第1301号. 学位記番号: 新大院博（医）乙第1209号. 学位授与年月日: 平成4年4月23日新潟医学会雑誌. 1992, 106(11), 1055-...
Patients affected by liver cirrhosis are at high risk for developing hepatocellular carcinoma (HCC)....
Background: Protein induced by vitamin K absence (PIVKA-II), also known as des-gamma-carboxyprothrom...
Background and Aims: Hepatocellular carcinoma (HCC) represents the second leading cause of cancer de...
Background. At present, the diagnostic accuracy of alpha-fetoprotein (AFP) for hepatocellular carcin...
Background and Aim: Alpha-fetoprotein (AFP), a lens culinaris agglutinin-reactive fraction of AFP (A...
Abstract Background Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is an efficient...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Early diagnosi...
The plasma concentrations of PIVKA-II in samples from 155 patients with HCC and 298 with other liver...
Background: Hepatocellular carcinoma is a common cancer worldwide and has a high mortality. Biomarke...
The use of tumor biomarkers, although debated, for the surveillance of patients at risk of HCC, is c...
Background & Aims: Protein induced by vitamin K absence or antagonist-II (PIVKA-II) has been sug...
Levels of alpha-fetoprotein (AFP), its glycoforms AFP-L3 and AFP-P4, and proteins induced by vitamin...
OBJECTIVE: As a marker for Hepatocellular Carcinoma (HCC), Protein Induced by Vitamin K Absence II (...
OBJECTIVE: α-Fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II ...
学位の種類: 博士（医学）. 報告番号: 乙第1301号. 学位記番号: 新大院博（医）乙第1209号. 学位授与年月日: 平成4年4月23日新潟医学会雑誌. 1992, 106(11), 1055-...
Patients affected by liver cirrhosis are at high risk for developing hepatocellular carcinoma (HCC)....
Background: Protein induced by vitamin K absence (PIVKA-II), also known as des-gamma-carboxyprothrom...
Background and Aims: Hepatocellular carcinoma (HCC) represents the second leading cause of cancer de...
Background. At present, the diagnostic accuracy of alpha-fetoprotein (AFP) for hepatocellular carcin...
Background and Aim: Alpha-fetoprotein (AFP), a lens culinaris agglutinin-reactive fraction of AFP (A...
Abstract Background Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is an efficient...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Early diagnosi...
The plasma concentrations of PIVKA-II in samples from 155 patients with HCC and 298 with other liver...
Background: Hepatocellular carcinoma is a common cancer worldwide and has a high mortality. Biomarke...
The use of tumor biomarkers, although debated, for the surveillance of patients at risk of HCC, is c...
Background & Aims: Protein induced by vitamin K absence or antagonist-II (PIVKA-II) has been sug...
Levels of alpha-fetoprotein (AFP), its glycoforms AFP-L3 and AFP-P4, and proteins induced by vitamin...
OBJECTIVE: As a marker for Hepatocellular Carcinoma (HCC), Protein Induced by Vitamin K Absence II (...
OBJECTIVE: α-Fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II ...
学位の種類: 博士（医学）. 報告番号: 乙第1301号. 学位記番号: 新大院博（医）乙第1209号. 学位授与年月日: 平成4年4月23日新潟医学会雑誌. 1992, 106(11), 1055-...